ERBB2 and breast carcinoma: The IRF6 expression level was significantly (p < 0.05) positive in Luminal A patients, and the correlation between NFIL3 gene expression levels and neutrophils was significantly (p < 0.05) positive in every breast cancer subtype, including Basal, Her2, Luminal A, and Luminal B.